期刊
ADVANCED DRUG DELIVERY REVIEWS
卷 62, 期 11, 页码 1031-1051出版社
ELSEVIER
DOI: 10.1016/j.addr.2010.09.007
关键词
Positron emission tomography (PET); Radiolabeling; Prosthetic group; C-11; N-13; O-15; Ga-68; F-18; Cu-64; I-124
资金
- Department of Energy [DE-SC0002353]
- USC Department of Radiology
- Provost's Biomedical Imaging Science Initiative
Molecular imaging is an emerging technology that allows the visualization of interactions between molecular probes and biological targets. Molecules that either direct or are subject to homeostatic controls in biological systems could be labeled with the appropriate radioisotopes for the quantitative measurement of selected molecular interactions during normal tissue homeostasis and again after perturbations of the normal state. In particular, positron emission tomography (PET) offers picomolar sensitivity and is a fully translational technique that requires specific probes radiolabeled with a usually short-lived positron-emitting radionuclide. PET has provided the capability of measuring biological processes at the molecular and metabolic levels in vivo by the detection of the gamma rays formed as a result of the annihilation of the positrons emitted. Despite the great wealth of information that such probes can provide, the potential of PET strongly depends on the availability of suitable PET radiotracers. However, the development of new imaging probes for PET is far from trivial and radiochemistry is a major limiting factor for the field of PET. In this review, we provided an overview of the most common chemical approaches for the synthesis of PET-labeled molecules and highlighted the most recent developments and trends. The discussed PET radionuclides include C-11 (t(1/2) = 20.4 min), N-13 (t(1/2) = 9.9 min), O-15 (t(1/2) = 2 min), Ga-68 (t(1/2) = 68 min), F-18 (t(1/2) = 109.8 min), Cu-64(t(1/2) = 12.7 h), and I-124 (t(1/2) = 4.12 d). (C) 2010 Published by Elsevier B.V.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据